Access Financial Services’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Access Financial Services’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4,017	Closed	-$465K	–	93
2023 Q3	$465K	Hold	4,017	–	–	0.28%	72
2023 Q2	$413K	Hold	4,017	–	–	0.24%	72
2023 Q1	$438K	Buy	4,017 +309	+8%	+$34.2K	0.27%	71
2022 Q4	$422K	Buy	+3,708	New	+$308K	0.26%	74
2022 Q3	–	Sell	-3,708	Closed	-$296K	–	100
2022 Q2	$296K	Hold	3,708	–	–	0.17%	94
2022 Q1	$390K	Buy	3,708 +437	+13%	+$42.6K	0.19%	95
2021 Q4	$352K	Hold	3,271	–	–	0.16%	100
2021 Q3	$358K	Hold	3,271	–	–	0.16%	95
2021 Q2	$306K	Hold	3,271	–	–	0.14%	105
2021 Q1	$301K	Buy	+3,271	New	+$276K	0.14%	90

Other funds holding HZNP

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Access Financial Services's HZNP Position: Q4 2023 in Review

Access Financial Services sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 4,017 shares — an estimated $465K sold.

Access Financial Services first reported a position in HZNP in Q1 2021 and held it in 10 quarters. The position peaked at $465K in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Access Financial Services reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Access Financial Services sold 4,017 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $465K.
Access Financial Services first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2021 and held it in 10 quarters.
Access Financial Services's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $465K in Q3 2023.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Access Financial Services's 13F filing for Q4 2023, filed 18 Jan 2024.